Nonhormonal Treatment Regimens Improve Survival In Patients With Metastatic Breast Cancer
Monday, December 22, 2008 - 23:43
in Health & Medicine
Nonhormonal treatment regimens, including anthracycline-based regimens and taxanes, have improved overall survival in women with advanced (metastatic or recurrent inoperable) breast cancer over the last 35 years, according to a systematic review in the Journal of the National Cancer Institute.